Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioAscent Discovery
BioAscent Discovery
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
BioAscent reports increasing demand for compound management
Throughout the last two years the company has invested over £1m in its compound management infrastructure and grown its team by 40%
Finance
BioAscent appoints two Associate Directors
Dr Angelo Pugliese and Dr McArthur will be working as Associate Director of in silico discovery and data analysis, and Associate Director of medicinal chemistry respectively
Manufacturing
BioAscent Discovery names Director of Business Development for North America
Julian Abery joins the company as a consultant to expand the company in the US market
Regulatory
Dr Phil Jones to join BioAscent as new CSO
Research & Development
BioAscent appoints new CEO and plans to expand discovery services
Mental Health
Merz outsources its compound management to BioAscent
BioAscent supplies screening plates on demand to provide flexible and cost-effective management of solid and liquid compounds
Ingredients
BioAscent expands compound management services offering in collaboration with Pierre Fabre
Will become the central hub for storage and logistics of Pierre Fabre's plant natural extracts collection
Subscribe now